Ludwig Enterprises (LUDG) Other financing activities (2023 - 2026)
Ludwig Enterprises posted quarterly Other financing activities of $184.0 for Q2 2025, down 99.65% on a QoQ basis from $52767.0 in Q1 2025.
Ludwig Enterprises (LUDG) has 3 years of Other financing activities data on file, last reported at $184.0 in Q2 2025.
- For the quarter ending Q2 2025, Other financing activities changed N/A year-over-year to $184.0; the trailing twelve-month figure through Dec 2025 stood at $52951.0 (changed N/A YoY), and the FY2025 full-year result was $52951.0, down 11.75% from the prior year.
- Other financing activities for Q2 2025 stood at $184.0, down from $52767.0 in the prior quarter.
- Across five years, Other financing activities topped out at $52767.0 in Q1 2025 and bottomed at -$23865.0 in Q1 2023.
- The 3-year median for Other financing activities is $5092.0 (2024), against an average of $9771.5.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ludwig Enterprises | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,883.00 |
| Mar 31, 2026 | 9,883.00 |
| Jun 30, 2025 | 184.00 |
| Jun 30, 2025 | 184.00 |
| Mar 31, 2025 | 52,767.00 |
| Mar 31, 2025 | 52,767.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Mar 31, 2023 | -23,865.00 |
| Mar 31, 2023 | -23,865.00 |